ÂÜÀòÂÒÂ×

Alexander Karl Huwig, Ph.D. has a diverse work experience in various companies and roles. Alexander Karl currently holds the position of Chief Scientific Officer at curasan AG since 2023. Prior to this, they worked at regenold GmbH as the Head of Preclinical Strategy & Development at CE plus, a division of regenold GmbH, from 2021 to 2023. Alexander Karl also served as the Regulatory Affairs Expert at CE plus from 2020 to 2021. Dr. Huwig has extensive experience in the oral care industry, where they worked as the Director Global R&D Oral Care at SUNSTAR Suisse SA/SUNSTAR Germany from 2018 to 2020 and as a Senior Manager in R&D Oral Care at Sunstar Suisse SA and Sunstar Germany from 2017 to 2018. In addition, they have experience in the biological measurement research and development department at Testo SE & Co. KGaA and as an R&D Manager Oral Care at Sunstar Suisse SA. Before that, they worked at Dentsply Sirona Implants as a Senior Manager in RD Bio/Regeneratives Platform and as a Senior Manager in Research, where they managed multiple implantable product development projects. Alexander Karl'searly career includes working at Ivoclar Vivadent AG, where they held the position of Manager of the Research & Development Unit of Professional Care/Biotechnology, responsible for the development of diagnostic and medical devices, biomaterials, and drugs for oral health care and oral tissue regeneration. Dr. Huwig has a Ph.D. in Biotechnology.

Alexander Karl Huwig Ph.D. received their Master (Dipl.-Biochem.) degree in Biochemistry from Leibniz Universität Hannover during the period of 1986 to 1992. Alexander Karl then pursued further studies at the University of the Saarland, Saarbrücken, Germany, where they obtained their Doctor of Philosophy (Ph.D.) degree in Microbiology, with a focus on the field of Microbiology, General, between 1992 and 1997. Following this, they undertook a postdoctoral fellowship at the University of the Saarland from 1997 to 1998, specializing in the area of Microbiology.